Asante Bio is a joint preservation company that develops revolutionary medical products for early intervention orthopaedic care.
Asante Bio has raised $256K in total funding. The most recent round was Grant. The last funding was announced in June 2022.
Asante Bio's investors include National Science Foundation.
Asante Bio is headquartered in Tampa, United States.
Asante Bio is a joint preservation company that develops revolutionary medical products for early intervention orthopaedic care.
Asante Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Asante Bio — Funding & Investors." VCBacked, June 1, 2022, https://www.vcbacked.co/company/asante-bio. Accessed September 30, 2026.
VCBacked. (2022). Asante Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/asante-bio
{{cite web |title=Asante Bio — Funding & Investors |url=https://www.vcbacked.co/company/asante-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated